NecstGen visits BIA Separations Inc./Sartorius in Slovenia

Last week, Diederik Lokhorst and Cristina Muñoz Lopez from NecstGen visited BIA Separations Inc./Sartorius in Slovenia for hands-on training in chromatography and analytical tools. This visit provided valuable insights into monolith technology and the PATfix analytical platform, supporting process monitoring and optimisation. “Overall, it was a very nice experience to be there. The team is […]

Last week, Diederik Lokhorst and Cristina Muñoz Lopez from NecstGen visited BIA Separations Inc./Sartorius in Slovenia for hands-on training in chromatography and analytical tools. This visit provided valuable insights into monolith technology and the PATfix analytical platform, supporting process monitoring and optimisation.

“Overall, it was a very nice experience to be there. The team is very knowledgeable and has a lot of passion for what they do. We have learned many new things, and it was fascinating to learn about their technologies, not only the monoliths but also the analytical tools like the PATfix.” – Cristina

Working alongside the experienced team at BIA Separations was an excellent opportunity to exchange knowledge and refine approaches for downstream processing. Their expertise and commitment to innovation were evident throughout the training sessions, and we look forward to applying these learnings in our work at NecstGen.

Interested in learning more about how we apply advanced chromatography in our manufacturing processes? Get in touch—we’d be happy to discuss how our expertise can support your Cell & Gene Therapy development.

The First Stages of CAR T Cell Therapy Development

The First Stages of CAR T Cell Therapy Development

Chimeric Antigen Receptor (CAR) T cell therapy represents a transformative approach in medicine, particularly in oncology. This method offers personalised treatment by harnessing a patient's immune system to target and eliminate (cancer) cells. These novel therapies...

Webinar LV Process for CAR T

Webinar LV Process for CAR T

Shifting from traditional, ad hoc methodologies to a structured, data-based development approach to create a scalable, GMP-ready process.

NecstGen Services

Cell Therapy Development & Manufacturing

Viral Vector Development & Manufacturing

Cleanroom Rental

About Us

NecstGen is a non-profit CDMO and Centre of Excellence for Cell and Gene Therapy located in a purpose-built GMP facility in Leiden, The Netherlands. Dedicated to the field of Cell and Gene Therapies, we provide expertise and capacity.

NecstGen

Team

Partners

History

Facility

Ecosystem